click below
click below
Normal Size Small Size show me how
Phar - Anti cell wal
Antimicrobial drugs
| Question | Answer |
|---|---|
| Cell wall inhibitors | Amoxicillin Cefaclor Ceftriaxone Dicloxacillin Meropenem Penicillin G Ticarcillin Vancomycin Daptomycin Isoniazid |
| Amoxicillin properties | Cell wall synthesis inhibitor, beta-lactam |
| Amoxicillin pharmacokinetics | Oral, kidney, variable CSF |
| Cefaclor properties | 2nd gen cephalosporin, beta-lactam, broader spectrum than penicillin, more resistant to beta-lactamases |
| Cefaclor pharmacokinetics | Oral, kidney, variable CSF |
| Ceftriaxone properties | 3rd gen cephalosporin, beta-lactam, broader spectrum than penicillin, more resistant to beta-lactamases |
| Ceftriaxone pharmacokinetics | Parenteral, kidney, variable CSF |
| Dicloxacillin properties | Beta-lactam, cell wall inhibitor |
| Dicloxacillin pharmacokinetics | Oral, kidney, variable CSF |
| Meropenem properties | Beta-lactam like, cell wall inhibitor |
| Meropenem pharmacokinetics | Parenteral, kidney, CSF |
| Penicillin G properties | Beta-lactam, cell wall inhibitor |
| Penicillin G pharmacokinetics | Oral, kidney, variable CSF |
| Ticarcillin properties | Beta-lactam, cell wall inhibitor |
| Ticarcillin pharmacokinetics | Parenteral, kidney, variable CSF |
| Vancomycin properties | Inhibits cell wall synthesis, blocks transfer step |
| Vancomycin pharmacokinetics | Parenteral, kidney, variable CSF |
| Daptomycin properties | Membrane disruptor, myopathy |
| Daptomycin pharmacokinetics | Parenteral, kidney, variable CSF |
| Isoniazid properties | Cell wall: inhibits FAS-II mycolic acid synthesis (pyridoxine deficiency, hepatoxic) |
| Isoniazid pharmacokinetics | Oral, liver, CSF |